Home › Funds › GordonMD Global Investments LP › VIR
GordonMD Global Investments LP position in VIR
VIR BIOTECHNOLOGY INC · Health Care
GordonMD Global Investments LP reported holding 803,552 shares of VIR (VIR BIOTECHNOLOGY INC) in its Q3 2026 13F filing — a position valued at US$9.0M, representing 5.40% of its reported portfolio and ranking #6 among its reported holdings. GordonMD Global Investments LP has disclosed VIR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GordonMD Global Investments LP's VIR position evolved
GordonMD Global Investments LP first disclosed a stake in VIR in Q4 2025 at 930,317 shares (US$5.6M). The position peaked in Q2 2026 at 1,353,552 shares, worth US$13.8M. Across 4 filings, GordonMD Global Investments LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 803,552 shares valued at US$9.0M — a reduction of -550,000 shares quarter over quarter.. Notable position changes include a 63% increase in Q1 2026 (shares rose 14% over the following quarter), a 41% trim in Q3 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 930.32K | $5.61M | New |
| Q1 2026 | 1.52M | $13.61M | Add |
| Q2 2026 | 1.35M | $13.79M | Reduce |
| Q3 2026 | 803.55K | $8.98M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VIR and 13F data
VIR (VIR BIOTECHNOLOGY INC) is a Health Care company. 42 other funds we track also report a position in VIR — the largest reported positions include ARCH Venture Management, LLC (US$129.4M), SB INVESTMENT ADVISERS (UK) LTD (US$111.6M), GSK plc (US$95.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VIR
- ARCH Venture Management, LLC 12.69M sh · $129.35M · Q2 2026
- SB INVESTMENT ADVISERS (UK) LTD 10.95M sh · $111.56M · Q2 2026
- GSK plc 8.55M sh · $95.60M · Q3 2026
- ADAR1 Capital Management, LLC 2.16M sh · $24.14M · Q3 2026
- Saturn V Capital Management LP 2.04M sh · $22.81M · Q3 2026
- Boxer Capital Management, LLC 1.87M sh · $19.01M · Q2 2026
- Sio Capital Management, LLC 873.38K sh · $9.76M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 578.70K sh · $6.47M · Q3 2026
More on GordonMD Global Investments LP
FAQ
How long has GordonMD Global Investments LP held VIR?
GordonMD Global Investments LP has disclosed VIR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is GordonMD Global Investments LP's current position in VIR?
As of Q3 2026, GordonMD Global Investments LP holds 803.55K shares of VIR (VIR BIOTECHNOLOGY INC), valued at $8.98M, representing 5.40% of its reported portfolio and ranking #6.
Has GordonMD Global Investments LP been buying or selling VIR?
In the latest 13F filing (Q3 2026), GordonMD Global Investments LP reduced its position in VIR. The position peaked in Q2 2026 at 1.35M shares.
Which other funds hold VIR?
Other major institutional holders of VIR include ARCH Venture Management, LLC, SB INVESTMENT ADVISERS (UK) LTD, GSK plc, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.